Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

医学 自杀意念 不良事件报告系统 药物警戒 不利影响 文拉法辛 优势比 精神科 奎硫平 双相情感障碍 内科学 毒物控制 心情 抗抑郁药 急诊医学 伤害预防 焦虑 精神分裂症(面向对象编程)
作者
Chiara Gastaldon,Emanuel Raschi,John M. Kane,Corrado Barbui,Georgios Schoretsanitis
出处
期刊:Psychotherapy and Psychosomatics [Karger Publishers]
卷期号:90 (1): 41-48 被引量:117
标识
DOI:10.1159/000510703
摘要

<b><i>Introduction:</i></b> Esketamine nasal spray received approval for treatment-resistant depression in March 2019. <b><i>Objective:</i></b> Using the FDA Adverse Event Reporting System (FAERS) database (March 2019–March 2020), we analysed esketamine-related adverse events (AEs) to detect and characterize relevant safety signals. <b><i>Methods:</i></b> We used the consolidated case/non-case approach to estimate the reporting odds ratio (ROR) and information component (IC) with relevant confidence intervals (95% CI) for esketamine-related AEs with ≥4 counts. Comparisons between serious and non-serious AEs were performed using non-parametric tests. <b><i>Results:</i></b> The FAERS database contained 962 cases of esketamine-related AEs, with signals detected for several AEs, such as dissociation (ROR = 1,612.64, 95% CI = 1,354.63, 1,919.79; IC = 8.19, 95% CI = 7.96, 8.35), sedation (ROR = 238.46, 95% CI = 202.98, 280.15; IC = 7, 95% CI = 6.75, 7.18), feeling drunk (ROR = 96.17, 95% CI = 61.42, 150.57; IC = 4.84, 95% CI = 4.09, 5.36), suicidal ideation (ROR = 24.03, 95% CI = 18.72, 30.84; IC = 4.31, 95% CI = 3.9, 4.61), and completed suicide (ROR = 5.75, 95% CI = 3.18, 10.41; IC = 2.25, 95% CI = 1.23, 2.94). Signals for suicidal and self-injurious ideation, but not suicide attempt and completed suicide, remained when comparing esketamine to venlafaxine. Females and patients receiving antidepressant polypharmacy, co-medication with mood stabilizers, antipsychotics, benzodiazepines, or somatic medications were more likely to suffer from serious versus non-serious AEs (χ<sup>2</sup> = 125.29, <i>p</i> &#x3c; 0.001, χ<sup>2</sup> = 9.08, <i>p</i> = 0.003, χ<sup>2</sup> = 8.14, <i>p</i> = 0.004, χ<sup>2</sup> = 19.48, <i>p</i> &#x3c; 0.001, χ<sup>2</sup> = 25.62, <i>p</i> &#x3c; 0.001, and χ<sup>2</sup> = 16.79, <i>p</i> &#x3c; 0.001, respectively). <b><i>Conclusions:</i></b> Esketamine may carry a clear potential for serious AEs, which deserves urgent clarification by means of further prospective studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
YY发布了新的文献求助10
刚刚
董晓萱发布了新的文献求助10
1秒前
锅锅完成签到,获得积分10
2秒前
darcy完成签到,获得积分10
2秒前
3秒前
烟花发布了新的文献求助10
4秒前
4秒前
JamesPei应助不知道叫什么采纳,获得10
4秒前
fchwpo发布了新的文献求助10
5秒前
完美世界应助邓d采纳,获得10
5秒前
YY完成签到,获得积分10
6秒前
7秒前
小二郎应助李健课题组采纳,获得10
7秒前
8秒前
yang应助Gpu_broken采纳,获得10
8秒前
董晓萱完成签到,获得积分20
8秒前
ezekiet发布了新的文献求助10
9秒前
yabocai发布了新的文献求助50
9秒前
vicky完成签到,获得积分10
9秒前
cdercder应助lhlhl采纳,获得20
9秒前
9秒前
科研通AI6.4应助晨晨采纳,获得10
9秒前
10秒前
10秒前
赘婿应助青青草采纳,获得30
11秒前
11秒前
微笑猎豹发布了新的文献求助10
12秒前
vicky发布了新的文献求助10
13秒前
无极微光应助淡淡咖啡豆采纳,获得20
13秒前
13秒前
Orange应助Willow采纳,获得10
13秒前
xiangwang发布了新的文献求助10
14秒前
烟花完成签到,获得积分10
15秒前
15秒前
Roxy完成签到,获得积分10
15秒前
makabaka完成签到,获得积分10
16秒前
16秒前
16秒前
16秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Environmental Leverage in Times of Climate Crisis: Product Standards, Carbon Border Measures and Preferential Trade Agreements 1000
Erwählung und Berufung bei Paulus: Bedeutung, Entwicklung und Funktion einer Vorstellung in ihrem frühjüdischen und griechisch-römischen Kontext 850
Matrix Methods in Data Mining and Pattern Recognition 510
Structural Geology: A Quantitative Introduction 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7216440
求助须知:如何正确求助?哪些是违规求助? 8848104
关于积分的说明 18672119
捐赠科研通 6872568
什么是DOI,文献DOI怎么找? 3185000
关于科研通互助平台的介绍 2346852
邀请新用户注册赠送积分活动 2159308